Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked ...

Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Cantor ...

Israeli mobile games developer Playtika Holding Corp. (Nasdaq: PLTK) has announced that it will acquire Israel-based mobile ...

Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million ...

Investing in quality exchange-traded funds can be a good way to grow your wealth conservatively and sleep well at night (SWAN ...

As of 17 September at 10:41 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

Bavaria's sophisticated capital serves as a gateway to some of Germany's best slopes. Bypass the crowded pistes of ...

Jefferies biotech analyst Michael Yee joins Market Domination to lay out his bull case on Gilead (GILD) and how investors should consider their biotech positions relative to the GLP-1 weight-loss ...